caa a22 4500 445315962 CHVBK 20180317142647.0 cr unu---uuuuu 170323e20110501xx s 000 0 eng 10.1007/s10552-011-9749-0 doi (NATIONALLICENCE)springer-10.1007/s10552-011-9749-0 Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors [Elektronische Daten] [William Carpenter, Wei-Shi Yeh, Sara Wobker, Paul Godley] Objective: Cancer incidence and mortality statistics provide limited insight regarding the cancer survivor population and its needs. Cancer prevalence statistics enumerate cancer survivors—those currently living with cancer. Commonly used limited-duration prevalence (LDP) methods yield biased estimates of the number of survivors. National estimates may not allow sufficient granularity to inform local survivorship programs. In this study, complete prevalence (CP) methods are applied to actual North Carolina Central Cancer Registry (NCCCR) data to generate better, more informative prevalence estimates than previous methods. Methods: Data included all incident cases for 1995-2007 from the NCCCR and US Census population data. SEER*Stat software was used to calculate 13-year LDP. ComPrev software was used to estimate CP for each cancer site, gender, and race combination. Results: CP methods estimated 362,810 survivors in North Carolina on January 1, 2008, 40% more than LDP estimates of 258,556, with substantial racial, regional, and gender differences in prevalence rankings of several cancers. Conclusion: CP estimates are substantially higher than previous prevalence estimates. This study found previously unrecognized racial, regional, and gender differences. State and local programs may apply these methods using their own data to develop better, more detailed estimates to improve planning for their specific survivor populations' needs. Springer Science+Business Media B.V., 2011 Cancer survivorship nationallicence Prevalence nationallicence Epidemiology nationallicence Methods nationallicence Program planning nationallicence Carpenter William Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, 1102A McGavran Greenberg Hall, CB 7411, 27599, Chapel Hill, NC, USA aut Yeh Wei-Shi Allergan, Inc., Irvine, CA, USA aut Wobker Sara UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA aut Godley Paul Cecil G. Sheps Center for Health Services Research, UNC, Chapel Hill, NC, USA aut Cancer Causes & Control Springer Netherlands 22/5(2011-05-01), 765-773 0957-5243 22:5<765 2011 22 10552 https://doi.org/10.1007/s10552-011-9749-0 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10552-011-9749-0 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Carpenter William Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, 1102A McGavran Greenberg Hall, CB 7411, 27599, Chapel Hill, NC, USA aut NATIONALLICENCE 700 1- Yeh Wei-Shi Allergan, Inc., Irvine, CA, USA aut NATIONALLICENCE 700 1- Wobker Sara UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA aut NATIONALLICENCE 700 1- Godley Paul Cecil G. Sheps Center for Health Services Research, UNC, Chapel Hill, NC, USA aut NATIONALLICENCE 773 0- Cancer Causes & Control Springer Netherlands 22/5(2011-05-01), 765-773 0957-5243 22:5<765 2011 22 10552 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer